Die Bedeutung von Stickstoff
monoxid (NO) für Nozizeption und spinale Schmerzverarbeitung

Zusammenfassung.

Stickstoffmonoxid (NO) ist als universelles Signaltransduktionsmolekül, wie vielfach belegt, auch an der Entstehung und Verarbeitung von Schmerzsignalen beteiligt. Die meisten dazu erhobenen tierexperimentellen Befunde sowie die wenigen Beobachtungen am Menschen deuten darauf hin, dass NO hauptsächlich dann eine Rolle spielt, wenn eine begleitende Entzündung vorliegt. Für den Akutschmerz sowie den chronischen Schmerz ohne ausgeprägte Entzündungskomponente hat das NO-System hingegen kaum Bedeutung; der in diesem Zusammenhang dennoch gelegentlich beobachtete antihyperalgetische Effekt von NO-Synthese-Inhibitoren lässt sich vor allem auf ihre vasokonstriktorische Nebenwirkung zurückführen. Bisher ist unklar, ob sich spezifische Beeinflussung der NO-Synthese oder -Wirkung zur Therapie oder Prophylaxe von Entzündungsschmerz beim Menschen nutzen lässt.

The Significance of Nitrogen Monoxide (NO) Concerning Nociception and Spinal Pain Processing.

Nitric oxide (NO) has been shown to be involved in the generation and processing of pain signals. Most experimental studies on animals and also the few observations in humans point to an involvement of the NO-system in inflammatory pain, whereas acute pain and chronic pain without inflammatory component seem to be independent of NO. It is yet unknown whether specific inhibition of the NO pathway is useful for treatment or prevention of inflammatory pain in humans.

NO - Schmerz - Sensibilisierung - Übersicht

NO - Pain - Sensitization - Review

Literatur

• 1 Tjolsen A. et al . The formalin test: an evaluation of the method.  Pain. 1992;  51 5-17
• 2 Moore P K. et al . 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure.  Br J Pharmacol. 1993;  108 296-297
• 3 Moore P K. et al . L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse.  Br J Pharmacol. 1991;  102 198-202
• 4 Malmberg A B, Yaksh T L. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats.  Pain. 1993;  54 291-300
• 5 Yamamoto T, Shimoyama N, Mizuguchi T. Nitric oxide synthase inhibitor blocks spinal sensitization induced by formalin injection into the rat paw.  Anesth Analg. 1993;  77 886-890
• 6 Meller S T, Gebhart G F. Nitric oxide (NO) and nociceptive processing in the spinal cord.  Pain. 1993;  52 127-136
• 7 Meller S T. et al . The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat.  Neuroscience. 1994;  60 367-374
• 8 Haley J E, Dickenson A H, Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat.  Neuropharmacology. 1992;  31 251-258
• 9 Radhakrishnan V, Henry J L. L-NAME blocks responses to NMDA, substance P and noxious cutaneous stimuli in cat dorsal horn.  Neuroreport. 1993;  4 323-326
• 10 Ma Q P, Woolf C J. Noxious stimuli induce an N-methyl-D-aspartate receptor-dependent hypersensitivity of the flexion withdrawal reflex to touch: implications for the treatment of mechanical allodynia.  Pain. 1995;  61 383-390
• 11 Malmberg A B, Yaksh T L. Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats.  J Neurosci. 1995;  15 2768-2776
• 12 Malmberg A B, Yaksh T L. The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats.  Br J Pharmacol. 1995;  114 1069-1075
• 13 Muth-Selbach U S. et al . Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation.  Anesthesiology. 1999;  91 231-239
• 14 Scheuren N. et al . Peripheral noxious stimulation releases spinal PGE2 during the first phase in the formalin assay of the rat.  Life Sci. 1997;  60 295-300
• 15 Ferreira S H, Lorenzetti B B. Intrathecal administration of prostaglandin E2 causes sensitization of the primary afferent neuron via the spinal release of glutamate.  Inflamm Res. 1996;  45 499-502
• 16 Minami T. et al . Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice.  Pain. 1994;  57 217-223
• 17 Uda R. et al . Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice.  Brain Res. 1990;  510 26-32
• 18 Park Y H. et al . The role of nitric oxide and prostaglandin E2 on the hyperalgesia induced by excitatory amino acids in rats.  J Pharm Pharmacol. 2000;  52 431-436
• 19 Geisslinger G, Yaksh T L. Spinal actions of cyclooxygenase inhibitors. Devor M, Rowbotham MC, Wiesenfeld-Hallin Z (Editors) Proceedings of the 9th World Congress on Pain, Progress in Pain Research and Management. IASP Press 2000: 771-785
• 20 Guhring H. et al . Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice.  J Neurosci. 2000;  20 6714-6720
• 21 Corrado A P, Ballejo G. Is guanylate cyclase activation through the release of nitric oxide or a related compound involved in bradykinin-induced perivascular primary afferent excitation?.  Agents Actions Suppl. 1992;  36 238-250
• 22 Nakamura A, Fujita M, Shiomi H. Involvement of endogenous nitric oxide in the mechanism of bradykinin-induced peripheral hyperalgesia.  Br J Pharmacol. 1996;  117 407-412
• 23 Holthusen H, Ding Z. Nitric oxide is not involved in vascular nociception of noxious physical stimuli in humans.  Neurosci Lett. 1997;  227 111-114
• 24 Holthusen H. Involvement of the NO/cyclic GMP pathway in bradykinin-evoked pain from veins in humans.  Pain. 1997;  69 87-92
• 25 Kindgen-Milles D, Arndt J O. Nitric oxide as a chemical link in the generation of pain from veins in humans.  Pain. 1996;  64 139-142
• 26 Aley K O, McCarter G, Levine J D. Nitric oxide signaling in pain and nociceptor sensitization in the rat.  J Neurosci. 1998;  18 7008-7014
• 27 Crosby G, Marota J J, Huang P L. Intact nociception-induced neuroplasticity in transgenic mice deficient in neuronal nitric oxide synthase.  Neuroscience. 1995;  69 1013-1017
• 28 Budzinski M. et al . Inhibition of inducible nitric oxide synthase in persistent pain.  Life Sci. 2000;  66 301-305
• 29 Semos M L, Headley P M. The role of nitric oxide in spinal nociceptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation.  Neuropharmacology. 1994;  33 1487-1497
• 30 Moncada S, Palmer R M, Higgs E A. Nitric oxide: physiology, pathophysiology, and pharmacology.  Pharmacol Rev. 1991;  43 109-142
• 31 Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Seattle. IASP Press 1994
• 32 Thomas D A. et al . Application of nitric oxide synthase inhibitor, N omega-nitro-L-arginine methyl ester, on injured nerve attenuates neuropathy-induced thermal hyperalgesia in rats.  Neurosci Lett. 1996;  210 124-126
• 33 Levy D, Zochodne D W. Local nitric oxide synthase activity in a model of neuropathic pain.  Eur J Neurosci. 1998;  10 1846-1855
• 34 Levy D, Hoke A, Zochodne D W. Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain.  Neurosci Lett. 1999;  260 207-209
• 35 Clatworthy A L. et al . Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain.  Neurosci Lett. 1995;  184 5-8
• 36 Inoue T. et al . Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model.  Brain Res. 1998;  792 263-270
• 37 Luo Z D. et al . Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: lack of a role in allodynia development.  J Neurosci. 1999;  19 9201-9208
• 38 Choi Y. et al . Neuropathic pain in rats is associated with altered nitric oxide synthase activity in neural tissue.  J Neurol Sci. 1996;  138 14-20
• 39 Steel J H. et al . Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model.  Neurosci Lett. 1994;  169 81-84
• 40 Pan H L, Chen S R, Eisenach J C. Role of spinal NO in antiallodynic effect of intrathecal clonidine in neuropathic rats.  Anesthesiology. 1998;  89 1518-1523
• 41 Devor M, Seltzer Z. Pathophysiology of damaged nerves in relation to chronic pain. In: Wall P, Melzack R (Editors) Textbook of Pain.  Churchill Livingstone 1999: 29-65
• 42 Hallin Z. et al . Nitric oxide mediates ongoing discharges in dorsal root ganglion cells after peripheral nerve injury.  J Neurophysiol. 1993;  70 2350-2353
• 43 Häbler H J. et al . Responses of axotomized afferents to blockade of nitric oxide synthesis after spinal nerve lesion in the rat.  Neurosci Lett. 1998;  254 33-36
• 44 Cousins M, Power I. Acute and postoperative pain. In: Wall P, Melzack R (Editors) Textbook of Pain. Churchill Livingstone 1999: 447-491
• 45 Nakamura A, Shiomi H. Recent advances in neuropharmacology of cutaneous nociceptors.  Jpn J Pharmacol. 1999;  79 427-431
• 46 Bennett G J, Xie Y K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.  Pain. 1988;  33 87-107
• 47 Kim S H, Chung J M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat.  Pain. 1992;  50 355-363
• 48 Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury.  Pain. 1990;  43 205-218